Education *CME

December 18, 2024

Managing Generalized Pustular Psoriasis

Managing Generalized Pustular Psoriasis From Flare to Maintenance: Optimizing Patient Outcomes reviews the latest clinical data on new and emerging interleukin (IL)-36 inhibitors for treating and preventing generalized pustular psoriasis (GPP) flares and discusses strategies to counsel patients on trigger avoidance, identifying flares, and flare prevention in GPP.

Download the Derm Care Companion.

Watch at dermsquared.com

Watch and earn credit
Share
Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2025 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.